Perrigo’s stock tumbles 14% after sales miss and lowered guidance

United States News News

Perrigo’s stock tumbles 14% after sales miss and lowered guidance
United States Latest News,United States Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

Perrigo Co. Plc’s stock PRGO, -0.97% fell 14% early Tuesday, after the consumer self-care and wellness products maker posted weaker-than-expected third-quarter sales and lowered its guidance. Dublin, Ireland-based Perrigo had net income of $14.2 million, or 10 cents a share, for the quarter, after a loss of $49.4 million, or 37 cents a share, in the year-earlier period.

Adjusted per-share earnings came to 64 cents, ahead of the 63 cent FactSet consensus. Sales rose 2.2% to $1.1 billion, just below the $1.2 billion FactSet consensus. The company is now expecting full-year adjusted EPS of $2.50 to $2.60, down from prior guidance of $2.50 to $2.70. It expects sales to grow 4% to 6%, down from prior guidance of 7% to 11%. The stock has fallen 16% in the year to date, while the S&P 500 SPX, +0.18% has gained 13.7%.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Organigram’s stock soars premarket as it receives C$124.6 million investment from BATOrganigram’s stock soars premarket as it receives C$124.6 million investment from BATCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »

AIG launches secondary offering of 50 million shares of former life and retirement business Corebridge FinancialAIG launches secondary offering of 50 million shares of former life and retirement business Corebridge FinancialCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »

Cargo Therapeutics to offer 18.8 million shares in IPO priced at $15 to $17 eachCargo Therapeutics to offer 18.8 million shares in IPO priced at $15 to $17 eachCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »

BioNTech’s stock rallies after it posts surprise Q3 profit and revenue that tops estimatesBioNTech’s stock rallies after it posts surprise Q3 profit and revenue that tops estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »

Align Technology to buy back $100 million of its common stockAlign Technology to buy back $100 million of its common stockCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »

BioNTech stock rallies after it posts surprise profit, revenue tops estimatesBioNTech stock rallies after it posts surprise profit, revenue tops estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »



Render Time: 2025-02-23 03:34:11